Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1996 1
1997 1
1998 2
1999 2
2000 2
2001 5
2002 5
2003 7
2004 9
2005 8
2006 5
2007 7
2008 5
2009 8
2010 6
2011 3
2012 7
2013 9
2014 4
2015 6
2016 7
2017 8
2018 3
2019 4
2020 6
2021 1
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009.
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2023 Aug;61(8):1046-1134. doi: 10.1055/a-2060-0935. Epub 2023 Aug 14. Z Gastroenterol. 2023. PMID: 37579791 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2).
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators. Kucharzik T, et al. Z Gastroenterol. 2024 May;62(5):769-858. doi: 10.1055/a-2271-0994. Epub 2024 May 8. Z Gastroenterol. 2024. PMID: 38718808 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline.
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2020 Dec;58(12):e241-e326. doi: 10.1055/a-1296-3444. Epub 2020 Dec 1. Z Gastroenterol. 2020. PMID: 33260237 German. No abstract available.
Tacrolimus--finally!
Herrlinger KR, Fellermann K, Stange EF. Herrlinger KR, et al. Among authors: fellermann k. Gut. 2006 Sep;55(9):1224-5. doi: 10.1136/gut.2006.093302. Gut. 2006. PMID: 16905691 Free PMC article.
Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine.
Pagel R, Bär F, Schröder T, Sünderhauf A, Künstner A, Ibrahim SM, Autenrieth SE, Kalies K, König P, Tsang AH, Bettenworth D, Divanovic S, Lehnert H, Fellermann K, Oster H, Derer S, Sina C. Pagel R, et al. Among authors: fellermann k. FASEB J. 2017 Nov;31(11):4707-4719. doi: 10.1096/fj.201700141RR. Epub 2017 Jul 14. FASEB J. 2017. PMID: 28710114 Free PMC article.
Thiopurines in inflammatory bowel disease revisited.
Bär F, Sina C, Fellermann K. Bär F, et al. Among authors: fellermann k. World J Gastroenterol. 2013 Mar 21;19(11):1699-706. doi: 10.3748/wjg.v19.i11.1699. World J Gastroenterol. 2013. PMID: 23555158 Free PMC article. Review.
6-thioguanine-buried alive?
Herrlinger KR, Schwab M, Fellermann K, Stange EF. Herrlinger KR, et al. Among authors: fellermann k. Gastroenterology. 2004 Mar;126(3):940-1; author reply 941-2. doi: 10.1053/j.gastro.2004.01.044. Gastroenterology. 2004. PMID: 14988863 No abstract available.
Therapeutic peptides in inflammatory bowel disease.
Herrlinger KR, Stange EF, Fellermann K. Herrlinger KR, et al. Among authors: fellermann k. Expert Opin Biol Ther. 2014 Apr;14(4):455-66. doi: 10.1517/14712598.2014.880109. Expert Opin Biol Ther. 2014. PMID: 24450849 Review.
123 results